We identified a rat cDNA that encodes carWfage homeoprotein 1 (Cart-i). The deduced amino acid sequence of Cart-I contains a paired-type homeodomain. Northem blot hybridization and RNase protection assay revealed that Cart-i RNA was present at high levels in a welldferentiated rat chondrosarcoma tumor and in a cell line derived from this tumor. Cart-i RNA was deed in priy mouse and rat chondrocytes but not in various flbroblasts including moue 10Th cells, NIH 3T3 cells, BALB 3T3 cells, and rat skin fibroblasts. It was also undetectable in mouse C2 myoblasts, S194 myeloma cells, and embryonic stem cells. Cart-1 RNA was present at a very low level in testes but was not detcted in other soft tissues of 8-week-old rats. In situ hybridization of rat embryos between 14.5 and 16.5 days post coitum revealed relativelyhigh levels of Cart-1 RNA in condensed prechondrocytic mesenchymal cells and in early chondrocytes of cartlage primordia. The levels of Cart-i RNA were lower in mature chondrocytes. No hybridization was observed in brain, spinal cord, heart, spleen, i tract, liver, and muscle. We speculate that Cart-i has a role in chondrocyte diferentiation.
In vertebrates, bones form through either an endochondral or an intramembranous mechanism. In endochondral bone formation, a cascade of events occurs, including the condensation of mesenchymal cells in which the expression of cartilage-specific genes is gradually switched on, the differentiation of the condensed mesenchymal cells into mature chondrocytes as cartilage-specific extracellular matrix accumulates, and the further differentiation of the mature chondrocytes into hypertrophic chondrocytes (1) . The hypertrophic chondrocytes are later replaced by invading osteoblast precursors. Recent evidence has indicated that bone morphogenetic proteins, which are members of the transforming growth factor P3 superfamily of cytokines, can cause cartilage and bone formation both in vitro and in vivo (2, 3) . Because transcription factors control numerous aspects of development and cellular differentiation (4, 5) , one can postulate that specific transcription factors probably also play important roles in determining the lineage specificity of prechondrocytic mesenchymal cells and in further controlling the onset of cartilage-specific gene expression.
Homeoproteins play major roles as transcription factors during embryonic development (6) (7) (8) (9) . These proteins can be subdivided into different classes based on their sequence homology in the homeodomain (10) . Hox genes are arranged in four clusters in mammalian genomes. The spatial and temporal expression of individual members of these clusters along the anterior-posterior axis of the embryo controls the The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. segmentation process during early development (9) . Other types of homeoproteins, such as HNF1 in liver (11) , TTF1 in thyroid (12) , and Pitl in pituitary gland (5) , participate in the regulation of tissue-specific gene expression. Still other homeoproteins including MHox (13) , S8 (14) , Moxl, and Mox2 (15) show an expression pattern that is restricted to mesenchymal cells and their derivatives. However, to our knowledge, no homeoproteins selectively expressed in the chondrocytic lineage have been described.
Here we report the identification and characterization of a cDNA that encodes cartilage homeoprotein 1 (Cart-1). § Cart-1 is selectively expressed in chondrocytes. In situ hybridization of rat embryos revealed that the Cart-i RNAs were present at high levels in the condensed mesenchymal cells that were the precursors of mature chondrocytes.
MATERIALS AND METHODS RNA Isolation. Total RNA from different tissues and cell lines was purified by guanidine thiocyanate/cesium chloride centrifugation and phenol/chloroform extraction. Poly(A)+ RNA was isolated by one or two rounds of chromatography over type II oligo(dT)-cellulose (Collaborative Research).
Molecular Cloning of Cart-i. First-strand cDNA was synthesized using a poly(A)+ RNA preparation from a rat chondrosarcoma tumor with avian myeloblastosis virus reverse transcriptase and a dT-adaptor. This dT-adaptor contained the Not I recognition sequence followed by 18 dT residues, 5'-AACCCGGCTCGAGCGGlCfCTTTTTT-TTTTTTTTTTTT-3' (underlined residues are for a Not I recognition site). Rapid amplification of cDNA ends by the polymerase chain reaction (PCR) was performed with firststrand cDNA using a Hom primer and a Not primer. This Hom primer, 5'-A(G)TC(G)AAG(A)A(G)TG(C/A/T)TGGT-TC(T)CAG(A)AA-3', was derived from the 7-aa consensus sequence V(I)KV(I)WFQN present in helix 3 of homeodomains. The Not primer, 5'-AACCCGGCTCGAGCCG-C TTTT-3', was identical to the 5' portion of dT-adaptor. The PCR products were digested with Not I and then cloned into Bluescript IIKS+ (Stratagene) between the EcoRV and Not I sites. Individual colonies that hybridized with a Hom probe were chosen for sequencing. This Hom probe, 5 (21) , TTF (12) , and Piti (5) are mouse homeooins.
Dashes represent amino acid residues identical to those of Cart-1.
regions were determined by restriction enzyme digestion and DNA sequencing (Fig. 1A) . 700-bp DNA fiament, generated by rapid amplifcation of cDNA ends by the PCR, located 3' to the Cart-i homeobox was hybridized to poly(A)+ RNA under moderately stringent conditions. Lanes: Rat Ch. Tumor, rat chondrosarcoma tumor; Rat Ch. Cells, a cell line derived from the rat chondrosarcoma tumor; WT2.7, a mouse chondrosarcoma-derived fibroblastic cell line that did not express detectable levels of proal(II) collagen RNA; lOT½, mouse C3H lOT½ cell line; NIH 3T3, mouse NIH 3T3 cell line; Rat Skin Fib., rat skin fibroblasts; C2, mouse C2 myoblasts; S194, mouse S194 myeloma cells; AML, human acute myelocytic leukemia blood sample; Daudi, a human B-lymphoma cell line; D14 rat emb., 14-day-old rat embryos. Approximately 10 Mg of RNA was used for the rat chondrosarcoma tumor and the 14-day-old rat embryos, "5 Mg of RNA was used for all other samples. The same membrane was stripped and rehybridized with 32P-labeled human ,-actin cDNA probe and is shown below the Cart-i blot. (B) RNase protection assay using an antisense RNA probe generated from Cart-300 with RNAs from different rat tissues and cell types. Lanes: RCS cell, a rat chondrosarcoma cell line; D14 re, 14-day-old rat embryos; D18 resk, 18-day-old rat embryo skeletal tissues; NB rib, newborn rat rib cartilage; D18 resf, a mixture of soft tissues from 18-day-old rat embryos; NB skin, newborn rat skin. Liver, spleen, lung, kidney, heart, brain, testis, and muscle are tissues from 8-week-old rats. (C) RNase protection assay using antisense RNA probe generated from mCart-200 and RNAs from different mouse cells. Lanes: chl2, primary mouse chondrocytes cultured as a monolayer for (24) . The 5' untranslated region contained three additional AUGs that were all closely followed by in-frame termination codons.
The sequence between aa 132 and 191 was homologous to other homeodomains. As shown in Fig. 1C, this Fig. 2A) . WT2.7 was a mouse chondrosarcoma-derived fibroblastic cell line (25) in which we were unable to detect any RNA for the chondrocyte-specific proal(II) collagen by Northern blot hybridization (data not shown).
We also used the more-sensitive RNase protection assays to examine the expression pattern of Cart-1 in various rat tissues and cell types. These included a rat chondrosarcoma cell line that was derived from the chondrosarcoma tumor and displays a chondrocytic phenotype; day 14 rat embryos; day 18 rat embryo skeletal tissues; newborn rat rib cartilage; day 18 rat embryo soft tissues; newborn rat skin; and liver, spleen, lung, kidney, heart, brain, muscle, and testes from 8-week-old rats (Fig. 2B) . Interestingly, Cart-1 RNA was detected in the rat chondrosarcoma cell line, day 14 rat embryos, day 18 rat embryo skeletal tissues, and newborn rat rib cartilage. A very low level of expression was detected in testes after longer autoradiography. Cart-i RNA was not detected in other tissues. We also examined the levels of Cart-i RNA in various mouse cell types by RNase protection assays, using as probe antisense RNA generated from mCart-200. As shown in Fig. 2C , Cart-i RNA was detected only in primary mouse chondrocytes, but not in WT2.7 cells, 1OTY2 cells, 714 cells (a subclone of the BALB 3T3 cell line), C2 myoblasts, S194 myeloma cells, and embryonic stem cells. The tissue distribution ofCart-1 RNA in 4-week-old mice was identical to that of 8-week-old rats (data not shown). Fig. 2D shows that primary mouse rib chondrocytes cultured in vitro for various periods of time still expressed Cart-i RNA. Mouse chondrocytes infected with a recombinant retrovirus cytes cultured for 2 days; chO5, primary mouse chondrocytes cultured for 5 days; chl2, primary mouse chondrocytes cultured for 12 days; chvt, primary mouse chondrocytes transformed with a retrovirus containing the simian virus 40 large tumor antigen gene. To control the RNA levels in B-D, each RNA sample (5 jg) was electrophoresed in formaldehyde/agarose gel and stained with ethidium bromide; these gels are shown below the RNase protection assays.
AD-Mevelopmental Biology: Zhao et al. (26) also contained low levels of Cart-1 RNA. We concluded from these experiments that the Cart-i gene was selectively expressed in chondrosarcoma tumor and cells derived from this tumor, uncultured chondrocytes, cultured chondrocytes after several passages, and even in transformed dedifferentiated chondrocytes in which no proal(II) collagen RNA was detected.
Expression of Cart-i RNA in Rat Embryos. To obtain additional knowledge regarding the cell specificity of Cart-1 expression during embryonic development, we examined the distribution of Cart-1 RNA by in situ hybridization of rat embryos 14.5-16.5 days p.c. Rat embryonic development in this period is comparable to mouse embryonic development 13-15 days p.c. The 14.5-day-p.c. rat embryos represent a developmental stage during which chondrocytes are active in depositing cartilage-specific extracellular matrix. 35S-labeled antisense RNA probes from Cart-600, Cart-400, and Cart-700 were used in these experiments. In situ hybridization with these three probes revealed identical patterns of hybridization on similar sections, strongly suggesting that the signals were not due to nonspecific binding. In addition, we also used sense RNA probes as controls that did not show detectable hybridization above background levels (data not shown). These experiments showed that Cart-1 RNA was present at relatively high concentrations in developing cartilage. The representative examples in Fig. 3 show Cart-i RNA in the developing ribs of a 14.5-day-p.c. embryo (Fig. 3 A and G) and a 16.5-day-p.c. embryo (Fig. 3 B and H) , in Meckel's cartilage of a 14.5-day-p.c. embryo (Fig. 3 C and I) , in the cricoid cartilage and thyroid cartilage of a 16.5-day-p.c. embryo (Fig. 3 D and J) , in the nasal septum of a 16.5-dayp.c. embryo (Fig. 3 E and K) , and in the iliac primordium of (G-L) Dark (Fig. 3 F and L) . The levels of Cart-i RNA were lower in mature chondrocytes indicated by arrows in Fig. 3 . We also noted that Cart-i RNA was absent from a number of tissues, including brain, spinal cord, heart, muscle, skin, liver, spleen, and the gastrointestinal system. These findings indicated that the Cart-1 gene was selectively expressed in chondrocytes, that it was expressed at relatively high levels in prechondrocytes and early chondrocytes, and that the levels of Cart-i RNA were lower in mature chondrocytes.
DISCUSSION
We identified a rat cDNA that encodes a homeoprotein, Cart-1. The deduced amino acid sequence of the Cart-i homeodomain shows 78% sequence identity to that of smox-3 (17), a homeoprotein from S. mansoni, and 75% sequence identity to the homeodomain of the Drosophila aristaless protein (18) . The Cart-1 homeodomain also shows substantial sequence identity with Pax-3 (19), MHox (13) , and S8 (14) but shows significantly less identity with other homeodomains (Fig. 1C) . This suggests that Cart-i may belong to the paired (Prd) family of homeoproteins, although in Cart-i glutamine replaces a conserved serine at position 9 in helix 3 of the homeodomain. Outside the homeodomain, no other sequence motifs found in other homeoproteins or in other transcription factors were identified in Cart-1.
In overlapping cDNAs that we cloned, we found no evidence for alternatively spliced Cart-i RNAs. In three cDNAs, relatively large 5' untranslated regions were identified that represented variously extended cDNAs corresponding to the same mRNA. The 5' untranslated sequence shown in Fig. 1B is also part of a single exon of >600 bp in agenomic DNA clone (data not shown).
Both Northern blot hybridization and RNase protection assays showed a unique pattern of expression of Cart-1 RNAs in various tissues and cell types. Cart-i RNA was found in primary chondrocytes, a highly differentiated rat chondrosarcoma tumor from which the Cart-i cDNAs were isolated, and a cell line that was derived from this tumor. Cart-i RNA was not detected in other tissues or cell types, although a low level of Cart-i mRNA was detected in testes by RNase protection assays. The low-level expression of Cart-i in testes raises the question about its possible role in this tissue. It will be necessary to determine in which cells of the testes Cart-i is expressed and also whether the Cart-i polypeptide is present in this tissue. It is interesting to note that chondrocytes transformed with the simian virus 40 large tumor antigen still expressed low levels of Cart-1 RNA even after numerous passages when proal(II) collagen RNA was no longer detected in these cells. In situ hybridization of rat embryos at 14.5-16.5 days p.c. showed relatively high levels of Cart-1 RNA in a number of cartilages and precartilaginous primordia. In each case, high RNA levels appeared to be present in condensed mesenchymal cells and early chondrocytes, whereas the levels of Cart-1 RNA were lower or undetectable in more mature chondrocytes. It should be noted that it is difficult to detect low RNA levels by in situ hybridization and that this method is less sensitive than the RNase protection assay, which detected Cart-1 RNA in rib chondrocytes from newborn rats and mice. Moreover, it is also possible that the Cart-1 polypeptide persists in cells and continues to exert its effects despite the decreased RNA levels.
Identifying Cart-1 expression in early development might 
